May 1 (UPI) --Pharmaceutical giant Johnson & Johnson on Wednesday said it is taking steps to resolve a multibillion dollar, cancer-related lawsuit with thousands of individuals over claims that ...
Benzinga - by Vandana Singh, Benzinga Editor. Wednesday, Johnson & Johnson (NYSE:JNJ) announced its intention to proceed with a $6.475 billion settlement to resolve numerous lawsuits related to ...
A subsidiary of Johnson & Johnson is now proposing to pay approximately $6.48 billion over 25 years as part of a settlement in the U.S. to cover allegations that its baby powder containing talc caused ...
The verdict in the 4th Judicial District Circuit Court in Portland comes as the company continues to pursue a proposed $6.48 billion settlement of most talc-related lawsuits against it through a ...
THE WHAT? The 4 th Judicial District Circuit Court in Portland has delivered the latest verdict in the ongoing talc litigation. Defendant Johnson & Johnson has been ordered to pay US$260 million in ...
Johnson & Johnson must pay US$260-million to an Oregon woman who said she developed a deadly cancer linked to asbestos exposure, from inhaling the company's talc powder, a jury found on June 3.
Johnson & Johnson’s MedTech division said Tuesday it plans to submit an application to the U.S. Food and Drug Administration next year to start clinical trials of its general surgery robot. Ottava, ...
Johnson & Johnson announced data from the Phase 3 PERSEUS study showing deepening of responses and sustained minimal residual disease negativity at both 10-5 and 10-6 levels with an induction regimen ...
Both these factors can be tied in part to J&J’s strong presence in the consumer sector – but behind household name products is a strong pharmaceutical backbone that has emerged over the ...
Samuel Johnson was born in Lichfield, Staffordshire, on 18 September 1709. His father was a bookseller. He was educated at Lichfield Grammar School and spent a brief period at Oxford University ...